1 November 2021 in Molecular Metabolism
Insulin regulates mitochondrial function, thereby propagating an efficient metabolism. Conversely, diabetes and insulin resistance are linked to mitochondrial dysfunction with a decreased expression of the mitochondrial chaperone HSP60. The aim of this investigation was to determine the effect of a reduced HSP60 expression on the development of obesity and insulin resistance. Control and heterozygous whole-body HSP60 knockout (Hsp60+/-) mice were fed a high-fat diet (HFD, 60% calories from fat) for 16 weeks and subjected to extensive metabolic phenotyping. To understand the effect of HSP60 on white adipose tissue, microarray analysis of gonadal WAT was performed, ex vivo experiments were performed, and a lentiviral knockdown of HSP60 in 3T3-L1 cells was conducted to gain detailed insights into the effect of reduced HSP60 levels on adipocyte homeostasis. Male Hsp60+/- mice exhibited lower body weight with lower fat mass. These mice exhibited improved insulin sensitivity compared to control, as assessed by Matsuda Index and HOMA-IR. Accordingly, insulin levels were significantly reduced in Hsp60+/- mice in a glucose tolerance test. However, Hsp60+/- mice exhibited an altered adipose tissue metabolism with elevated insulin-independent glucose uptake, adipocyte hyperplasia in the presence of mitochondrial dysfunction, altered autophagy, and local insulin resistance. We discovered that the reduction of HSP60 in mice predominantly affects adipose tissue homeostasis, leading to beneficial alterations in body weight, body composition, and adipocyte morphology, albeit exhibiting local insulin resistance.
1 April 2023 in Diabetologie und Stoffwechsel
Obesity is associated with insulin and leptin resistance, which affects peripheral tissues as well as the brain. The novel density-enhanced phosphatase-1 (DEP-1), is a known negative modulator of insulin and leptin signaling. Intriguingly, diet-induced obese mice have increased DEP-1 expression in metabolic sensitive tissues, including the brain. In this study, the regulation of DEP-1-dependent metabolic effects was investigated in vitro and in vivo. To study the functional consequences of DEP-1 deficiency in vitro, we established a DEP-1 knockout (DEP-1 KO) in mouse undifferentiated dopaminergic-like Neuro-2a cells using CRISPR/Cas9. Additionally, we investigated the metabolic consequences of DEP-1 deficiency in the brain by crossing Dep-1 lox/lox mice to forebrain hippocampus-specific CamKIIa Cre mice and fed them a normal chow diet (NCD). DEP-1 KO cells portrayed a significant increase in phospho-ERK signaling upon acute insulin challenge shown by western blot analysis, suggestive of enhanced insulin signalling. Moreover, female DEP-1 KO mice fed a NCD revealed an increase in white-adipose tissue weight along with elevated adipogenic gene markers. On the other hand, male DEP-1 KO mice displayed significant upregulation in brown adipose tissue (BAT) gene markers in addition to an increase in protein expression of the different oxidative phosphorylation complexes subunits, indicating increased oxidative phosphorylation capacity in BAT of male DEP-1 KO mice [1] [2] [3] [4] [5]. This suggests that while in vitro DEP-1 deficiency subtly improves insulin sensitivity, DEP-1 KO mice demonstrate DEP-1 as a potential neuronal modulator of energy metabolism. Article published online: 02 May 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany